Aortic endograft infection with Mycobacterium bovis following intravesical BCG immunotherapy diagnosed via the Karius Test™- case report and review of literature
Bacillus Calmette-Guérin (BCG), a live attenuated form of Mycobacterium bovis, is utilized in non–muscle-invasive bladder cancer therapy. Disseminated BCG infection causing vascular graft infection is extremely rare. In this report, we review the literature and describe a rare case of aortic endograft infection in a 72- year-old man, who underwent intravesical BCG treatment four years ago that was diagnosed utilizing next generation sequencing technique via the Karius test™ enabling earlier diagnosis and treatment start compared to conventional microbiological diagnostic tools. The morbidity and mortality from aortic graft infections remain high, therefore prompt diagnosis and multidisciplinary approach is paramount.
Authors
- Klaus Schäfer
- Jason Cook
- Jonathan Robert Thompson (ORCID: https://orcid.org/0000-0003-0512-1226)
- Richard Hankins (ORCID: https://orcid.org/0000-0002-8763-3374)
- Prateek Sharma (ORCID: https://orcid.org/0000-0003-4695-8698)
Institutions
- Nebraska Medical Center (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- Annals of Vascular Surgery - Brief Reports and Innovations
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.avsurg.2025.100376
- Primary Topic
- Infectious Aortic and Vascular Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00